Clinical Trial

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
Protocol Amendment History 31 amendments
This ClinicalTrials.gov record has been amended 31 times since 2023-10-27; most recent amendment 2026-07-23.
Status change: Not Yet Recruiting → Recruiting 2024-02-02
Trial Details
NCT Number NCT06113237
Lead Sponsor Jazz Pharmaceuticals
Conditions Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse, Pregnancy
Enrollment 50 participants
Start Date 2025-08-05
Primary Completion 2033-08-31 (estimated)
Study Completion 2033-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-24